MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties

Experimental Cell Research

Volumn 319, Issue 3, 2013, Pages 77-88

  Tominaga, Eiji ^a   Yuasa, Katsutoshi ^a   Shimazaki, Sho ^a   Hijikata, Takao ^a  

^a MUSASHINO UNIVERSITY   (Japan)

Author keywords

A549 cells; Adherens junction; E cadherin; MiR 1; Slug

Indexed keywords

DOXORUBICIN; LUCIFERASE; MICRORNA 1; OCCLUDIN; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VINCULIN;

A549 CELL; ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOINFORMATICS; CANCER CELL; CELL JUNCTION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SENSITIVITY ANALYSIS;

EID: 84872380374     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.10.015     Document Type: Article

References (51)

1. Parkin D.M., Bray F., Ferlay J, Pisani P. Global cancer statistics. J. Clin. 2005, 55:74-108.
2. Prudkin L., Liu D.D., Ozburn N.C., Sun M., Behrens C., Tang X., Brown K.C., Bekele B.N., Moran C., Wistuba I.I. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod. Pathol. 2009, 22:668-678.
3. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell. 2008, 14:818-829.
4. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
5. Funasaka T., Hu H., Yanagawa T., Hogan V., Raz A. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Cancer Res. 2007, 67:4236-4243.
6. Chou T.Y., Chen W.C., Lee A.C., Hung S.M., Shih N.Y., Chen M.Y. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cell. Signal 2009, 21:704-711.
7. Yauch R.L., Januario T., Eberhard D.A., Cavet G., Zhu W., Fu L., Pham T.Q., Soriano R., Stinson J., Seshagiri S., Modrusan Z., Lin C.Y., O'Neill V., Amler L.C. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin. Cancer Res. 2005, 11:8686-8698.
8. Thomson S., Buck E., Petti F., Griffin G., Brown E., Ramnarine N., Iwata K.K., Gibson N., Haley J.D. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 2005, 65:9455-9462.
9. Witta S.E., Gemmill R.M., Hirsch F.R., Coldren C.D., Hedman K., Ravdel L., Helfrich B., Dziadziuszko R., Chan D.C., Sugita M., Chan Z., Baron A., Franklin W., Drabkin H.A., Girard L., Gazdar A.F., Minna J.D., Bunn P.A. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006, 66:944-950.
10. Saxena S., Jónsson Z.O., Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 2003, 278:44312-44319.
11. Liu J., Valencia-Sanchez M.A., Hannon G.J., Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell. Biol. 2005, 7:719-723.
12. Nasser M.W., Datta J., Nuovo G., Kutay H., Motiwala T., Majumder S., Wang B., Suster S., Jacob S.T., Ghoshal K. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 2008, 283:33394-33405.
13. Nohata N., Sone Y., Hanazawa T., Fuse M., Kikkawa N., Yoshino H., Chiyomaru T., Kawakami K., Enokida H., Nakagawa M., Shozu M., Okamoto Y., Seki N. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2011, 2:29-42.
14. Yoshino H., Enokida H., Chiyomaru T., Tatarano S., Hidaka H., Yamasaki T., Gotannda T., Tachiwada T., Nohata N., Yamane T., Seki N., Nakagawa M. Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem. Biophys. Res. Commun. 2011, 417:588-593.
15. Kojima S., Chiyomaru T., Kawakami K., Yoshino H., Enokida H., Nohata N., Fuse M., Ichikawa T., Naya Y., Nakagawa M., Seki N. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br. J. Cancer 2012, 106:405-413.
16. Hijikata T., Lin Z.X., Holtzer S., Choi J., Sweeney H.L., Holtzer H. Unanticipated temporal and spatial effects of sarcomeric alpha-actinin peptides expressed in PtK2 cells. Cell. Motil. Cytoskeleton 1997, 38:54-74.
17. Geiger B., Tokuyasu K.T., Dutton A.H., Singer S.J. Vinculin, an intracellular protein localized at specialized sites where microfilament bundles terminate at cell membrane. Proc. Nat. Acad. Sci. U.S.A. 1980, 77:4127-4131.
18. Weiss E.E., Kroemker M., Rüdiger A.-H., Jockusch B.M., Rüdiger M. Vinculin is part of the cadherin-catenin junctional complex: Complex formation between a-catenin and vinculin. J. Cell. Biol. 1998, 141:755-764.
19. Peinado H., Olmeda M., Cano A. Snail, Zeb and bHLH factors in tumor progression: an alliance against the epithelial phnotype?. Nat. Rev. Cancer 2007, 7:415-428.
20. Kwon C., Han Z., Olson E.N., Srivastava D. MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling. Proc. Nat. Acad. Sci. U.S.A. 2005, 102:18986-18991.
21. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
22. Hudson R.S., Yi M., Esposito D., Watkins S.K., Hurwitz A.A., Yfantis H.G., Lee D.H., Borin J.F., Naslund M.J., Alexander R.B., Dorsey T.H., Stephens R.M., Croce C.M., Ambs S. MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res. 2012, 40:3689-3703.
23. Zhang K.J., Wang D.S., Zhang S.Y., Jiao X.L., Li C.W., Wang X.S., Yu Q.C., Cui H.N. The E-cadherin repressor Slug and progression of human extrahepatic hilar cholangiocarcinoma. J. Exp. Clin. Cancer Res. 2010, 29:88.
24. Liu Y.N., Abou-Kheir W., Yin J.J., Fang L., Hynes P., Casey O., Hu D., Wan Y., Seng V., Sheppard-Tillman H., Martin P., Kelly K. Critical and reciprocal regulation of KLF4 and Slug in transforming growth factor Β-initiated prostate cancer epithelial-mesenchymal transition. Mol. Cell. Biol. 2012, 32:941-953.
25. Wu K., Zeng J., Zhou J., Fan J., Chen Y., Wang Z., Zhang T., Wang X., He D. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development. Urol. Oncol. 2012, 12:91.
26. Hajra K.M., Chen D.Y., Fearon E.R. The Slug zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002, 62:1613-1618.
27. Bolós V., Peinado H., Pérez-Moreno M.A., Fraga M.F., Esteller M., Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell. Sci. 2003, 116:499-511.
28. Martínez-Estrada O.M., Cullerés A., Soriano F.X., Peinado H., Bolós V., Martínez F.O., Reina M., Cano A., Fabre M., Vilaró S. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem. J. 2006, 394:449-457.
29. Wang Z., Wade P., Mandell K.J., Akyildiz A., Parkos C.A., Mrsny R.J., Nusrat A. Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor Slug. Oncogene 2007, 26:1222-1230.
30. Zhang K., Chen D., Jiao X., Zhang S., Liu X., Cao J., Wu L., Wang D. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab. Invest. 2011, 91:426-438.
31. Tang P., Yu Z., Zhang K., Wang Y., Ma Z., Zhang S., Chen D., Zhou Y. Slug down-regulation by RNA interference inhibits invasion growth in human esophageal squamous cell carcinoma. BMC Gastroenterol. 2011, 11:60.
32. Savagner P., Kusewitt D.F., Carver E.A., Magnino F., Choi C., Gridley T., Hudson L.G. Developmental transcription factor Slug is required for effective re-epithelialization by adult keratinocytes. J. Cell. Physiol. 2005, 202:858-866.
33. Uygur B., Wu W.S. Slug promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol. Cancer 2011, 10:139.
34. Camp E.R., Findlay V.J., Vaena S.G., Walsh J., Lewin D.N., Turner D.P., Watson D.K. Slug expression enhances tumor formation in a noninvasive rectal cancer model. J. Surg. Res. 2011, 170:56-63.
35. Turner F.E., Broad S., Khanim F.L., Jeanes A., Talma S., Hughes S., Tselepis C., Hotchin N.A. Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. J. Biol. Chem. 2006, 281:21321-21331.
36. Dhasarathy A., Phadke D., Mav D., Shah R.R., Wade P.A. The transcription factors Snail and Slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS One 2011, 6:e26514.
37. Wang F., Song G., Liu M., Li X., Tang H. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett. 2011, 585:3263-3269.
38. Roy R., Yang J, Moses M.A. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 2009, 27:5287-5297.
39. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004, 6:17-32.
40. Ali S., Lazennec G. Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev. 2007, 26:401-420.
41. Johnson E.L., Singh R., Singh S., Johnson-Holiday C.M., Grizzle W.E., Partridge E.E., Lillard J.W. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J. Surg. Oncol 2010, 8:62.
42. Shih J.Y., Tsai M.F., Chang T.H., Chang Y.L., Yuan A., Yu C.J., Lin S.B., Liou G.Y., Lee M.L., Chen J.J., Hong T.M., Yang S.C., Su J.L., Lee Y.C., Yang P.C. Transcription repressor Slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin. Cancer Res. 2005, 11:8070-8078.
43. Shioiri M., Shida T., Koda K., Oda K., Seike K., Nishimura M., Takano S., Miyazaki M. Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br. J. Cancer 2006, 94:1816-1822.
44. Zhang K.J., Zhang B.Y., Zhang K.P., Tang L.M., Liu S.S., Zhu D.M., Zhang D.L. Clinicopathologic significance of Slug expression in human intrahepatic cholangiocarcinoma. World J. Gastroenterol. 2010, 16:2554-2557.
45. Vitali R., Mancini C., Cesi V., Tanno B., Mancuso M., Bossi G., Zhang Y., Martinez R.V., Calabretta B., Dominici C., Raschellà G. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models. Clin. Cancer Res. 2008, 14:4622-4630.
46. Wu W.S., Heinrichs S., Xu D., Garrison S.P., Zambetti G.P., Adams J.M., Look A.T. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005, 123:641-653.
47. Bermejo-Rodríguez C., Pérez-Caro M., Pérez-Mancera P.A., Sánchez-Beato M., Piris M.A., Sánchez-García I. Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts. Genomics 2005, 87:113-118.
48. Zhang K., Zhang S., Jiao X., Wang H., Zhang D., Niu Z., Shen Y., Lv L., Zhou Y. Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo. Med. Oncol. 2011, 28:1089-1100.
49. Zhang K., Chen D., Wang X., Zhang S., Wang J., Gao Y., Yan B. RNA Interference Targeting Slug Increases Cholangiocarcinoma Cell Sensitivity to Cisplatin via Upregulating PUMA. Int. J. Mol. Sci. 2011, 12:385-400.
50. Vannini I., Bonafe M., Tesei A., Rosetti M., Fabbri F., Storci G., Ulivi P., Brigliadori G., Amadori D., Zoli W. Short interfering RNA directed against the Slug gene increases cell death induction in human melanoma cell lines exposed to cisplatin and fotemustine. Cell. Oncol. 2007, 29:279-287.
51. Jiang W., Pang X.G., Wang Q., Shen Y.X., Chen X X.K., Xi J.J. Prognostic Role of Twist, Slug, and Foxc2 Expression in Stage I Non-Small-Cell Lung Cancer After Curative Resection. Clin. Lung. Cancer 2012, 13:280-287.